Lots of good material despite covering a broad subject area. Phase 2 lecturer and content was the highlight for me. As was the case in the related Discovery course, the Development course content is primarily drawn from a series of guest lectures as opposed to content designed from the ground up specifically for this Coursera class. An unfortunate result is rushed and/or glossed over topics. For instance, the Phase 1 guest lecturer ran out of time and skipped several slides he was planning on covering. There was also a drop off in usefulness for me in terms of Phase 3 clinical design considerations and evaluations.

Thisa course was very intersting to learn more about new drug application 2 years before applying to the FDA, the week 2 and 3 clinical trials and regulatory aspects were very interesting. The format of assessment can be like content of 3/4 page and then the individual selects an option as to what to do to rectify the information. That is a more efficient process to creatively think and do the regulations job in a real world scenario. I had no hesitation in doing this course and would do it again. Very useful for my background of medical technician and analytical chemistry degrees.

The initial sections of the course was interesting like preclinical and clinical, but some improvements needed for the later part of the course like NDA and commercialization. Overall, the content of the course needs to be updated to reflect the current pharma development process in terms of drug spending; approval time and new FDA review pathways; no, of drugs approved by each review pathway; and latest therapeutic advancements happening and how FDA views them. Hope these points will be considered in improving the course learning relevant to the current times.

I think the Course name should be changed - Drug Development - Clinical Trials through the phases.

It is super useful for people wanting to learn about clinical trials, it is mostly about clinical trials BUT the name of the course doesn't convey this, so a propospective employer in clinical trials wont care about this course because the name isnt informative enough about what you taught

This course adequately introduced the issues and the reality of the drug development process through the several expert presenters. Being interested in this field as an outsider, I appreciate the level of detail shared in the course. However, similar to the first part of the Coursera Specialization where this course belongs, the material seems outdated as well.

Very good talks and presentations, amazing speakers, lots of interesting information, very valuable course.

But OLD - the course needs major renewal, with new data and new talks. Same for power point presentations: most of them are totally useless, hard to understand and follow and just do not look nice. Please prepare better presentations for the next course.

Overall the content was relevant to drug development and presented in an organized manner. The presenters seemed to have a wealth of experience in development. This was my first time using Coursera and I enjoyed being able to pick up where I left off. I was disappointed with the course transcriptions as there were many inaccuracies.

I recommend this course together with Drug Discovery and Drug commercialization to everybody that would like to have an overview of pharmaceutical industry, however one should also keep in mind that these lectures are from 2013. It would be better if the lectures were more up to date. Then, I would give 5 stars.

The course is enriched with a lot of information that I learnt, but its just the first and second weeks tutors aren't suitable for teaching, their dialects aren't English. But all in all it was a great course and I may return and take the other 2 courses in this specialization.

How glad i am, this was fantastic, its an excellent course and i believe i have done tremendously well. Thank you UC SAN DIEGO in collaboration with coursera, i wish to progress to my masters degree if i can get an opportunity to the university of UC SAN DIEGO.

I truly enjoyed the lecture content and am thankful for the course.

For me, the lectures in week 3 need to be updated and changed. I was confused by the two lecturers taking on each other. I found the lecture material of the others speakers better organized

This is an informative course on clinical trial development and regulatory considerations of drug development. However, I wish the course content is more updated and organized. The lecture videos are the just recordings from their classes in 2013.

I was looking for a course that would give me a general idea of drug development and that could help me fill in the gaps that I had on this subject. I found this course very interesting and useful. The only flaw: it could be more up to date.

Course materials are useful, lectures are very easy to understand, some of the video / sound editing is a bit unclear, since you can't see the presenter talk when the slides are being shown. Overall, a great intro to drug development.

Robust review of the intricacies of the clinical trial process and economic considerations throughout. My only regret is that the data is a bit dated (ending 2012/13) and I am curious to see how things have shifted since then.

The course started well. But the course about Phase 2 was difficult to digest. Even worst, the course about NDA was long, repetitive, with old data (as old as 2003 !) and some regulation from 2009 ! It need a serious update.

Overall, I liked this course. There are some improvements I would suggest: > list online resources more clearly > define acronyms and provide better definitions > quizzes need to be longer and slightly more challenging

The drug labeling seminar was not very informative. Both the presenters seemed to be wanting to go one-up on the other with their respective experiences. The entire session was too casual to be labeled as a lecture.

I would like to see more updated information (i.e. more information on biologicals), current presentation is a bit old (from 2008-2010?)

But it provides good general overview of the clinical development process.

I liked the content but I feel it wasn't very engaging and each slide had a lot of text. If there were peer review assignments and activities other than quizzes, the course would have been more interesting.

The course was informative and found exactly at the time of need. I was a little disappointed because it's not the latest updated version. looking forward to the updated version of the course.

It is really informative and nice to learn about such a vast and growing industry. The only complain I have is all the data was from 2012 which has now either been changed or updated.

The course should be updated. Most of the data presented is almost a decade old. Also, The person who teaches about Phase II trails is not clear, and it is hard to understand him.

I would have loved to have a specific case study to follow as an example of how a drug goes through the whole life cycle as the course felt a bit too high-level overview at times.

The course is well organized, but it requires an update of the contents.

It is good for starting and refreshing the topic of clinical trials. I look for the next updated one!